Activation of p38 MAPK Pathway by Hepatitis C Virus E2 in Cells Transiently Expressing DC-SIGN

Cell Biochemistry and Biophysics

Volumn 56, Issue 1, 2010, Pages 49-58

  Chen, Qiu Li ^a   Zhu, Shi Ying ^a   Bian, Zhong Qi ^b   Zhao, Lan Juan ^a   Cao, Jie ^a   Pan, Wei ^a   Qi, Zhong Tian ^a  

^a SECOND MILITARY MEDICAL UNIVERSITY   (China)

^b KUNMING GENERAL HOSPITAL   (China)

Author keywords

DC SIGN; E2; Hepatitis C virus; P38 MAPK; Receptor

Indexed keywords

ACTIVATING TRANSCRIPTION FACTOR 2; CD209 ANTIGEN; CELL ADHESION MOLECULE; CELL SURFACE RECEPTOR; DC-SPECIFIC ICAM-3 GRABBING NONINTEGRIN; GLYCOPROTEIN E2, HEPATITIS C VIRUS; GREEN FLUORESCENT PROTEIN; LECTIN; MITOGEN ACTIVATED PROTEIN KINASE P38; VIRUS ENVELOPE PROTEIN;

ANIMAL; ARTICLE; CELL LINE; DRUG EFFECT; GENE EXPRESSION REGULATION; GENETICS; HEPATITIS C VIRUS; HUMAN; KINETICS; METABOLISM; PHYSIOLOGY; PLASMID; SIGNAL TRANSDUCTION; SPECTROFLUOROMETRY; TIME;

ACTIVATING TRANSCRIPTION FACTOR 2; ANIMALS; CELL ADHESION MOLECULES; CELL LINE; GENE EXPRESSION REGULATION; GREEN FLUORESCENT PROTEINS; HEPACIVIRUS; HUMANS; KINETICS; LECTINS, C-TYPE; MAP KINASE SIGNALING SYSTEM; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PLASMIDS; RECEPTORS, CELL SURFACE; SPECTROMETRY, FLUORESCENCE; TIME FACTORS; VIRAL ENVELOPE PROTEINS;

EID: 77951216026     PISSN: 10859195     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12013-009-9069-0     Document Type: Article

References (33)

1. Gardner, J. P., Durso, R. J., Arrigale, R. R., Donovan, G. P., Maddon, P. J., Dragic, T., et al. (2004). L-SIGN (CD 209L) is a liver-specific capture receptor for hepatitis C virus. Proceedings of the National Academy of Sciences of the United States of America, 100, 4498-4503.
2. Wu, L., Martin, T. D., Vazeux, R., Unutmaz, D., & KewalRamani, V. N. (2002). Functional evaluation of DC-SIGN monoclonal antibodies reveals DC-SIGN interactions with ICAM-3 do not promote human immunodeficiency virus type 1 transmission. Journal of Virology, 76, 5905-5914.
3. Puig-Kroger, A., Serrano-Gomez, D., Caparros, E., Dominguez-Soto, A., Relloso, M., Colmenares, M., et al. (2004). Regulated expression of the pathogen receptor dendritic cell-specific intercellular adhesion molecule 3 (ICAM-3)-grabbing nonintegrin in THP-1 human leukemic cells, monocytes, and macrophages. The Journal of Biological Chemistry, 279, 25680-25688.
4. Lozach, P. Y., Burleigh, L., Staropoli, I., & Amara, A. (2007). The C type lectins DC-SIGN and L-SIGN: Receptors for viral glycoproteins. Methods in Molecular Biology, 379, 51-68.
5. Geijtenbeek, T. B., Kwon, D. S., Torensma, R., van Vliet, S. J., van Duijnhoven, G. C., Middel, J., et al. (2000). DC-SIGN, a dendritic cell-specific HIV-1-binding protein that enhances transinfection of T cells. Cell, 100, 587-597.
6. de Witte, L., Abt, M., Schneider-Schaulies, S., van Kooyk, Y., & Geijtenbeek, T. B. (2006). Measles virus targetsDC-SIGN to enhance dendritic cell infection. Journal of Virology, 80, 3477-3486.
7. Kong, K. F., Delroux, K., Wang, X., Qian, F., Arjona, A., Malawista, S. E., et al. (2008). Dysregulation of TLR3 impairs the innate immune response to West Nile virus in the elderly. Journal of Virology, 82, 7613-7623.
8. Rosa, D., Saletti, G., De Gregorio, E., Zorat, F., Comar, C., D'Oro, U., et al. (2005). Activation of nai{dotless}̈ve B lymphocytes via CD81, a pathogenetic mechanism for hepatitis C virus-associated B lymphocyte disorders. Proceedings of the National Academy of Sciences of the United States of America, 102, 18544-18549.
9. Lozach, P. Y., Lortat-Jacob, H., de Lavalette, A., Staropoli, I., Foung, S., Amara, A., et al. (2003). DC-SIGN and L-SIGN are high affinity binding receptors for hepatitis C virus glycoprotein E2. The Journal of Biological Chemistry, 278, 20358-20366.
10. Pohlmann, S., Zhang, J., Baribaud, F., Chen, Z., Leslie, G. J., Lin, G., et al. (2003). Hepatitis C virus glycoproteins interact with DC-SIGN and DC-SIGNR. Journal of Virology, 77, 4070-4080.
11. Lozach, P. Y., Amara, A., Bartosch, B., Virelizier, J. L., Arenzana-Seisdedos, F., Cosset, F. L., et al. (2004). C-type lectins L-SIGN and DC-SIGN capture and transmit infectious hepatitis C virus pseudotype particles. The Journal of Biological Chemistry, 279, 32035-32045.
12. Ludwig, I. S., Lekkerkerker, A. N., Depla, E., Bosman, F., Musters, R. J., Depraetere, S., et al. (2004). Hepatitis C virus targets DC-SIGN and L-SIGN to escape lysosomal degradation. Journal of Virology, 78, 8322-8332.
13. Cormier, E. G., Durso, R. J., Tsamis, F., Boussemart, L., Manix, C., Olson, W. C., et al. (2004). L-SIGN (CD209L) and DC-SIGN (CD209) mediate transinfection of liver cells by hepatitis C virus. Proceedings of the National Academy of Sciences of the United States of America, 101, 14067-14072.
14. Savopoulos, J. W., Dowd, S., Armour, C., Carter, P. S., Greenwood, C. J., Mills, D., et al. (2002). Expression and purification of functional JNK2beta2: Perspectives on high-level production of recombinant MAP kinases. Protein Expression and Purification, 24, 25-32.
15. Kan, H., Xie, Z., & Finkel, M. S. (2004). p38 MAP kinasemediated negative inotropic effect of HIV gp120 on cardiac myocytes. American Journal of Physiology. Cell Physiology, 286, C1-C7.
16. Rahaus, M., Desloges, N., & Wolff, M. H. (2004). Replication of varicella-zoster virus is influenced by the levels of JNK/SAPK and p38/MAPK activation. Journal of General Virology, 85, 3529-3540.
17. Giambartolomei, S., Covone, F., Levrero, M., & Balsano, C. (2001). Sustained activation of the Raf/MEK/Erk pathway in response to EGF in stable cell lines expressing the Hepatitis C Virus (HCV) core protein. Oncogene, 20, 2606-2610.
18. Erhardt, A., Hassan, M., Heintges, T., & Haussinger, D. (2002). Hepatitis C virus core protein induces cell proliferation and activates ERK, JNK, and p38 MAP kinases together with theMAP kinase phosphatase MKP-1 in a HepG2 Tet-Off cell line. Virology, 292, 272-284.
19. Hassan, M., Ghozlan, H., & Abdel-Kader, O. (2005). Activation of c-Jun NH2-terminal kinase (JNK) signaling pathway is essential for the stimulation of hepatitis C virus (HCV) non-structural protein 3 (NS3)-mediated cell growth. Virology, 333, 324-336.
20. Huang, Y., Chen, X. C., Konduri, M., Fomina, N., Lu, J., Jin, L., et al. (2006). Mechanistic link between the anti-HCV effect of interferon gamma and control of viral replication by a Ras-MAPK signaling cascade. Hepatology, 43, 81-90.
21. Zhao, L. J., Wang, L., Ren, H., Cao, J., Li, L., Ke, J. S., et al. (2005). Hepatitis C virus E2 protein promotes human hepatoma cell proliferation through the MAPK/ERK signaling pathway via cellular receptors. Experimental Cell Research, 305, 23-32.
22. Zhao, L. J., Zhang, X. L., Zhao, P., Cao, J., Cao, M. M., Zhu, S. Y., et al. (2006). Up-regulation of ERK and p38 MAPK signaling pathways by hepatitis C virus E2 envelope protein in human T lymphoma cell line. Journal of Leukocyte Biology, 80, 424-432.
23. Pohlmann, S., Baribaud, F., Lee, B., Leslie, G. J., Sanchez, M. D., Hiebenthal-Millow, K., et al. (2001). DC-SIGN interactions with human immunodeficiency virus type 1 and 2 and simian immunodeficiency virus. Journal of Virology, 75, 4664-4672.
24. Aoki, H., Hayashi, J., Moriyama, M., Arakawa, Y., & Hino, O. (2000). Hepatitis C virus core protein interacts with 14-3-3 protein and activates the kinase Raf-1. Journal of Virology, 74, 1736-1741.
25. He, Y., Nakao, H., Tan, S. L., Polyak, S. J., Neddermann, P., Vijaysri, S., et al. (2002). Subversion of cell signaling pathways by hepatitis C virus nonstructural 5A protein via interaction with Grb2 and P85 phosphatidylinositol 3-kinase. Journal of Virology, 76, 9207-9217.
26. Sun, Y., Yuan, J., Liu, H., Shi, Z., Baker, K., Vuori, K., et al. (2004). Role of Gab1 in UV-induced c-Jun NH2-terminal kinase activation and cell apoptosis. Molecular and Cellular Biology, 24, 1531-1539.
27. Petracca, R., Falugi, F., Galli, G., Norais, N., Rosa, D., Campagnoli, S., et al. (2000). Structure-function analysis of hepatitis C virus envelope-CD81 binding. Journal of Virology, 74, 4824-4830.
28. Peng, T., Kotla, S., Bumgarner, R. E., & Gustin, K. E. (2006). Human rhinovirus attenuates the type I interferon response by disrupting activation of interferon regulatory factor 3. Journal of Virology, 80, 5021-5031.
29. Qi, X., Tang, J., Pramanik, R., Schultz, R. M., Shirasawa, S., Sasazuki, T., et al. (2004). p38 MAPK activation selectively induces cell death in K-ras-mutated human colon cancer cells through regulation of vitamin D receptor. The Journal of Biological Chemistry, 279, 22138-22144.
30. Park, K. J., Choi, S. H., Choi, D. H., Park, J. M., Yie, S. W., Lee, S. Y., et al. (2003). Hepatitis C virus NS5A protein modulates c-Jun N-terminal kinase through interaction with tumor necrosis factor receptor-associated factor 2. The Journal of Biological Chemistry, 278, 30711-30718.
31. Balasubramanian, A., Ganju, R. K., & Groopman, J. E. (2003). Hepatitis C virus and HIV envelope proteins collaboratively mediate interleukin-8 secretion through activation of p38 MAP kinase and SHP2 in hepatocytes. The Journal of Biological Chemistry, 278, 35755-35766.
32. Duyndam, M. C., van Dam, H., van der Eb, A. J., & Zantema, A. (1996). The CR1 and CR3 domains of the adenovirus type 5 E1A proteins can independently mediate activation of ATF-2. Journal of Virology, 70, 5852-5859.
33. Hall, D. J., Bates, M. E., Guar, L., Cronan, M., Korpi, N., & Bertics, P. J. (2005). The role of p38 MAPK in rhinovirus-induced monocyte chemoattractant protein-1 production by monocyticlineage cells. Journal of Immunology, 174, 8056-8063.